Millendo Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of new treatments for endocrine diseases with significant unmet medical needs. The company's primary focus is on creating distinct and transformative treatments where current therapies are insufficient. Millendo is currently working on advancing its lead candidate drug, MLE-301, for the treatment of vasomotor symptoms in women experiencing menopause.
Millendo Therapeutics, Inc.'s ticker is MLND
The company's shares trade on the NASDAQ stock exchange
They are based in Ann Arbor, Michigan
There are 11-50 employees working at Millendo Therapeutics, Inc.
It is https://millendo.com/
Millendo Therapeutics, Inc. is in the Healthcare sector
Millendo Therapeutics, Inc. is in the Biotechnology industry
The following five companies are Millendo Therapeutics, Inc.'s industry peers: